AN

Arun Namdeo Dusunge

Active Director Director DIN 10456737
DIN 10456737 First appointment Jan 2024 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Arun Namdeo Dusunge

Data last updated:

Arun Namdeo Dusunge is a Director at Xenrich Pharma Private Limited (since 2024). The company operates in Chemicals. Xenrich Pharma Private Limited reported revenue of ₹1.28 Cr (FY 2025).

DIN 10456737
Primary Designation Director
Industry Chemicals
First Appointment 08 Jan 2024
Oldest Company Age 6 yrs
Largest company Xenrich Pharma Private Limited · ₹1.28 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xenrich Pharma Private Limited U24232PN2020PTC194247
Director08 Jan 20242020₹1.28 Cr (FY 2025)Active

Board colleagues of Arun Namdeo Dusunge

Directorship timeline

Open interactive timeline →
Xenrich Pharma Private Limited
Premium access

Shareholding and investment profile for Arun Namdeo Dusunge

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Namdeo Dusunge

Arun Namdeo Dusunge currently holds 1 directorship: Xenrich Pharma Private Limited (Director, since 08 Jan 2024, revenue ₹1.28 Cr (FY 2025)).

Arun Namdeo Dusunge was first appointed on 08 Jan 2024 as Director at Xenrich Pharma Private Limited.

The current boards of Arun Namdeo Dusunge's companies include Hemant Shamrao Shinde (Xenrich Pharma Private Limited), Ritesh Sanjay Dhussa (Xenrich Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available